WSA
DRNA

Wall Street Associates’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Wall Street Associates’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11,400
Closed -$322K – 340
2014
Q1 		$322K Buy
+11,400
New +$322K 0.03% 298